CrossRef Integrated lifestyle management to mitigate MASLD risk in patients with chronic kidney disease: a prospective cohort study Chao Yan, Xinxin Shen, Shaojie Han, Jinzheng He, Tongxu Wang, Xiaobing Gong, Jindong Ding Petersen Journal of Translational Medicine .2026;[Epub] CrossRef Retatrutide in type 2 diabetes mellitus and obesity: an overview Theodoros Panou, Evanthia Gouveri, Djordje S
[A 45-fold liraglutide overdose did not cause hypoglycaemia]
Health Canada typically reviews obesity medications on timelines of 1-2 years following FDA approval in the United States
Blue Cross and Blue Shield of New Mexico does not dictate or direct providers in the practice of medicine, nor the exercise of medical judgment, nor making health care service treatment decisions
You also need to ask them about prior authorization and which drugs are included
Semaglutide can be taken long-term under medical supervision